UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Net income	$ 5,190	$ 3,319
Depreciation	334	354
Amortization	1,305	767
Gain on investments		(6)
Provision for losses on accounts receivable	8	8
Deferred income taxes	(428)	(174)
Stock-based compensation expense	38	49
Accounts receivable - trade	(275)	429
Accrued interest and other receivables	(89)	(40)
Inventories	183	(531)
Prepaid expenses and other current assets	62	43
Accounts payable	429	(174)
Accrued expenses	(170)	(26)
Deferred revenue	(50)	(21)
Other liability		449
Total adjustments	1,347	1,128
Net cash provided by operating activities	6,537	4,447
Capital expenditures for property and equipment	(133)	(158)
Capital expenditures for intangible assets	(1)	(7)
Purchases of investments		(500)
Proceeds from sale of investments		15,155
Net cash paid in acquisition		(41,084)
Net cash (used in) provided by investing activities	(134)	(26,594)
Proceeds from issuance of common stock - options	978	375
Common stock purchased and retired
Tax benefit attributable to exercise of stock options	99	23
Proceeds from notes payable		26,934
Repayments of notes payable	(5,221)	(1,927)
Payment of dividends	(878)	(851)
Net cash used in financing activities	(5,021)	24,555
Effect of exchange rate changes on cash	(3)	41
NET INCREASE (DECREASE) IN CASH	1,378	2,449
CASH AT BEGINNING OF PERIOD	6,534	3,818
CASH AT END OF PERIOD	7,913	6,267
Cash paid during the period for income taxes	2,021	1,470
Cash paid during the period for interest	$ 360	$ 354